EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Safety and Efficacy of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Cerebrovascular Ischemic Outcomes in Non‐Valvular Atrial Fibrillation: A Systematic Review and Meta‐Analysis

Anam Nasir, Naqash Anwar, Abdullah Bin Kamran, Ayesha Muhammad, Ali Haider, Muhammad Mubashar, Fatima Tariq, Mostafa Helou, Besher Shami iD

Clinical Cardiology · 2026-04 · 49 (4)

DOI: 10.1002/clc.70308 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical Cardiology, online erschienen am 17.04.2026. Verfasst von Anam Nasir und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of South China, Hengyang, Hunan, China. Hauptthemen laut MEDLINE: Atrial Fibrillation, Vitamin K, Anticoagulants, Brain Ischemia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atrial fibrillation (AF) is a major cause of thromboembolic events, including ischemic stroke and transient ischemic attack (TIA). While Vitamin K antagonists (VKAs) have long been used for stroke prevention, Direct Oral Anticoagulants (DOACs) have emerged as potential alternatives due to improved pharmacologic profiles and safety. This systematic review and meta‐analysis aimed to compare the efficacy and safety of DOACs versus VKAs in patients with non‐valvular AF, with a focus on cerebrovascular ischemic outcomes.

Methods

A comprehensive search of PubMed, ClinicalTrials.gov, and Cochrane Library was performed in accordance with PRISMA 2020 guidelines. Randomized controlled trials and comparative observational studies reporting cerebrovascular events, major bleeding, and all‐cause mortality were included. Pooled risk ratios (RR) with 95% confidence intervals (CI) were calculated using a random‐effects model.

Results

Eleven studies encompassing 814 716 patients were included. DOAC use was associated with a significantly lower risk of recurrent cerebrovascular ischemic events compared with VKAs (RR 0.83, 95% CI 0.78–0.88, p < 0.0001). The risk of major bleeding was also reduced with DOACs (RR 0.77, 95% CI 0.71–0.82, p < 0.0001). All‐cause mortality was similar between groups (RR 1.02, 95% CI 0.34–3.13), though sensitivity analysis excluding one heterogeneous study favored DOACs (RR 0.79, 95% CI 0.63–0.98).

Conclusion

In patients with non‐valvular AF, DOACs demonstrate superior efficacy in reducing cerebrovascular ischemic outcomes and lower bleeding risk compared to VKAs, with comparable mortality outcomes. These findings support current guidelines recommending DOACs as first‐line anticoagulation for stroke prevention in AF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationVitamin KAnticoagulantsBrain IschemiaIschemic StrokeStrokeHumansAdministration, OralTreatment OutcomeRisk Factors

Substanzen

Vitamin KAnticoagulants

Autor:innen und Institutionen

  • University of South China, Hengyang, Hunan, China.
  • Department of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan.
  • Nanchang University, Nanchang, China.
  • Gannan Medical University, Ganzhou, China.
  • University of Aleppo, Faculty of Medicine, Aleppo, Syria.
  • Berkshire Medical Center, Pittsfield, Massachusetts, USA.

ORCID-Profile: Besher Shami

Zitieren

APA

Nasir, A., Anwar, N., Kamran, A. B., Muhammad, A., Haider, A., Mubashar, M., Tariq, F., Helou, M., & Shami, B. (2026). Safety and Efficacy of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Cerebrovascular Ischemic Outcomes in Non‐Valvular Atrial Fibrillation: A Systematic Review and Meta‐Analysis. Clinical Cardiology, 49(4). https://doi.org/10.1002/clc.70308

Vancouver

Nasir A, Anwar N, Kamran AB, Muhammad A, Haider A, Mubashar M, et al. Safety and Efficacy of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Cerebrovascular Ischemic Outcomes in Non‐Valvular Atrial Fibrillation: A Systematic Review and Meta‐Analysis. Clinical Cardiology. 2026;49(4). doi:10.1002/clc.70308

BibTeX
@article{Nasir2026,
  author = {Nasir, Anam and Anwar, Naqash and Kamran, Abdullah Bin and Muhammad, Ayesha and Haider, Ali and Mubashar, Muhammad and Tariq, Fatima and Helou, Mostafa and Shami, Besher},
  title = {Safety and Efficacy of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Cerebrovascular Ischemic Outcomes in Non‐Valvular Atrial Fibrillation: A Systematic Review and Meta‐Analysis},
  journal = {Clinical Cardiology},
  year = {2026},
  volume = {49},
  number = {4},
  doi = {10.1002/clc.70308}
}
Kostenlos starten →